Disclosure Panels Details Page
Head and Neck Cancers Panel - Disclosures as of 06/21/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Douglas Adkins MD | Blueprint Medicines Bristol Myers Squibb Celgene Corporation Celldex Therapeutics Eisai Inc. Eli Lilly and Company Exelixis Inc. Kura Oncology, Inc. Merck & Co., Inc. Pfizer Inc. Roche Laboratories, Inc. |
Blueprint Medicines Exelixis Inc. Kura Oncology, Inc. Merck & Co., Inc. |
None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| David Brizel MD | Biomimetix | None | None | None | ✔ |
| Jennifer Burns BS | None | None | None | None | ✔ |
| Paul Busse MD, PhD | None | None | None | None | - |
| Jimmy Caudell MD, PhD | Varian Medical Systems, Inc. | None | None | None | ✔ |
| Anthony Cmelak MD | None | None | None | None | ✔ |
| A. Dimitrios Colevas MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP atara Audro Biotech BeiGene Bristol Myers Squibb Cell Sight cellsight COTA Inc. cue biopharma cullinan Exelixis Inc. Gilead Sciences, Inc. Innate innate pharma iqvia Keyquest LOXO Oncology pds biotechnology corporation Pfizer Inc. PRA health sciences rakuten tessa Threshold Pharmaceuticals |
None | None | None | ✔ |
| Susan Darlow PhD | None | None | None | None | ✔ |
| David Eisele MD, FACS | None | None | None | None | ✔ |
| Robert Foote MD, FACR, FASTRO | Hitachi Ltd | Alliance for Proton Therapy Access Cancer Terminator Foundation |
None | Bionix-patent rights-royalties from sales|Elsevier-Text Book Senior Editor-Royalties|UpToDate-Royalties for Content on Esthesioneuroblatoma | ✔ |
| Thomas Galloway MD | None | Naveris | Varian Medical Systems, Inc. | None | ✔ |
| Jessica Geiger MD | Alkermes Genentech, Inc. Regeneron Pharmaceuticals, Inc. |
Regeneron Pharmaceuticals, Inc. | None | None | ✔ |
| Maura Gillison MD, PhD | BioMimetix Bristol Myers Squibb Genentech, Inc. Genocea Biosciences Kura Oncology, Inc. |
Bayer HealthCare Bicara Therapeutics BioNTech EMD Serono Merck & Co., Inc. Mirati Therapeutics Roche Laboratories, Inc. Sensei Shattuck Labs |
None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Robert Haddad MD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Genentech, Inc. GSK Kura Oncology, Inc. Merck & Co., Inc. Pfizer Inc. |
Achilles AstraZeneca Pharmaceuticals LP Bayer HealthCare BioNTech Bristol Myers Squibb Celgene Corporation Eisai Inc. Genentech, Inc. Gilead Sciences, Inc. GSK IO Biotech Kura Oncology, Inc. Merck & Co., Inc. Vaccinex |
isa nanobiotix |
None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Laura Hanisch PsyD | None | None | None | None | - |
| Wesley Hicks, Jr. MD | Tactiva (start up Biotechnology Firm) | None | None | None | ✔ |
| Ying Hitchcock MD | None | None | None | None | ✔ |
| Anne Holbrook PharmD, BCOP | None | None | None | None | ✔ |
| Antonio Jimeno MD, PhD | Bristol Myers Squibb Cantargia Debiopharma Genocea Iovance Khar Merck & Co., Inc. Moderna SQZ |
None | None | Champions Oncology, Inc.|SuviCa | ✔ |
| Debra Leizman MD | None | None | None | None | ✔ |
| Ellie Maghami MD, FACS | None | None | None | None | ✔ |
| Loren Mell MD | AstraZeneca Pharmaceuticals LP Merck & Co., Inc. |
None | None | None | - |
| Bharat Mittal MD | None | None | None | None | ✔ |
| David Pfister MD | AstraZeneca Pharmaceuticals LP Atara GSK Hookipa MedImmune Inc. Meira Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | None | ✔ |
| Harlan Pinto MD | None | None | None | None | ✔ |
| James Polson BSRT (R) (CT) (MR) | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| James Rocco MD, PhD | None | None | None | None | ✔ |
| Cristina Rodriguez MD | Acerta Pharma AstraZeneca Pharmaceuticals LP Ayala Bristol Myers Squibb Genentech, Inc. Incyte Corporation Kura Oncology, Inc. Merck & Co., Inc. Pharmacyclics Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. |
Cue Biopharma | None | None | ✔ |
| David Schwartz MD | None | None | None | None | ✔ |
| Jatin Shah MD, PhD | None | None | None | None | ✔ |
| David Sher MD, MPH | None | None | None | None | ✔ |
| Sharon Spencer MD | None | None | None | None | ✔ |
| Maie St. John MD, PhD | None | None | None | None | ✔ |
| Amanda Visnick BSN, RN, OCN | None | None | None | None | ✔ |
| Randal Weber MD | None | None | None | None | ✔ |
| Gregory Weinstein MD | None | None | None | Olympus Corporation | ✔ |
| Francis Worden MD | Soligenix | Bristol Myers Squibb CUE Biopharma Eisai Eli Lilly and Company Kura Oncology, Inc. LOXO Merck & Co., Inc. Oragenics Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Justine Yang Bruce MD | Astellas Pharma US, Inc. Cellectar Biosciences Incyte Corporation Kura Oncology, Inc. Lilly Merck & Co., Inc. Nektar Therapeutics Seattle Genetics, Inc. Sensei |
Genzyme Corporation Phoenix Solutions |
None | None | - |
| Sue Yom MD, PhD | BioMimetix Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. |
None | None | Springer|Up To Date | ✔ |
| Weining Zhen MD | None | None | None | None | ✔ |